CIR clinics in revalidatie Revenue and Competitors

Zwolle, NLD

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CIR clinics in revalidatie's estimated annual revenue is currently $56.4M per year.(i)
  • CIR clinics in revalidatie's estimated revenue per employee is $383,878

Employee Data

  • CIR clinics in revalidatie has 147 Employees.(i)
  • CIR clinics in revalidatie grew their employee count by 24% last year.

CIR clinics in revalidatie's People

NameTitleEmail/Phone
1
Medical Director/ Consultant in Physical Medicine and RehabilitationReveal Email/Phone
2
RegiomanagerReveal Email/Phone
3
Regiomanager CIR clinics in revalidatie zwolle/ GroningenReveal Email/Phone
4
Administratief casemanagerReveal Email/Phone
5
LocatiecoördinatorReveal Email/Phone
6
PlannerReveal Email/Phone
7
PsycholoogReveal Email/Phone
8
Coördinator revalidatietraject/ErgotherapeutReveal Email/Phone
9
Revalidatiearts/Rehabilitation PhysicianReveal Email/Phone
10
GZ-psycholoogReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.1M11513%N/AN/A
#2
$109.4M3248%N/AN/A
#3
$51.1M17224%N/AN/A
#4
$329.6M8727%N/AN/A
#5
$24.3M90-2%N/AN/A
#6
$67.1M2261%N/AN/A
#7
$86.7M29222%N/AN/A
#8
$296.4M7843%N/AN/A
#9
$21.6M80-66%N/AN/A
#10
$35.6M132-1%N/AN/A
Add Company

What Is CIR clinics in revalidatie?

CIR voert poliklinische revalidatiebehandelingen uit. Meer lezen? Kijk op www.cir.nl\n\nHet CIR verzorgt innovatieve poliklinische revalidatiebehandelingen . Onderscheidend aan de aanpak is de focus op maatschappelijke, sociale en arbeidsgerelateerde participatie en de aandacht voor zelfredzaamheid en autonomie. De doelgroep waar het CIR zich op richt zijn mensen met chronische vermoeidheidsklachten en chronische pijnklachten.

keywords:N/A

N/A

Total Funding

147

Number of Employees

$56.4M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$41.5M1545%N/A
#2
$22.4M160158%N/A
#3
$54.2M17036%N/A
#4
$15M17819%N/A
#5
$24.9M17819%N/A